J. F. Desnottes

714 total citations
27 papers, 572 citations indexed

About

J. F. Desnottes is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, J. F. Desnottes has authored 27 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 12 papers in Molecular Medicine and 11 papers in Epidemiology. Recurrent topics in J. F. Desnottes's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Pneumonia and Respiratory Infections (7 papers). J. F. Desnottes is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Pneumonia and Respiratory Infections (7 papers). J. F. Desnottes collaborates with scholars based in France, Austria and Australia. J. F. Desnottes's co-authors include Bernard Scorneaux, A. Zenebergh, Marianne Carlier, Paul M. Tulkens, Sophie Sablé, Francis Blanche, François‐Xavier Bernard, Jean Provost, Béatrice Cameron and J Crouzet and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

J. F. Desnottes

25 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. F. Desnottes France 14 186 186 153 144 104 27 572
E. L. Moss United States 15 139 0.7× 233 1.3× 180 1.2× 190 1.3× 193 1.9× 28 649
Barbara A. Pelak United States 14 329 1.8× 302 1.6× 241 1.6× 180 1.3× 205 2.0× 28 939
KANJI TSUCHIYA Japan 14 207 1.1× 303 1.6× 219 1.4× 152 1.1× 93 0.9× 47 652
Masaya Takei Japan 15 346 1.9× 264 1.4× 246 1.6× 162 1.1× 117 1.1× 22 772
Axel Dalhoff Germany 13 201 1.1× 250 1.3× 348 2.3× 248 1.7× 116 1.1× 24 780
Patrick Plésiat France 8 232 1.2× 150 0.8× 355 2.3× 84 0.6× 60 0.6× 12 548
John O. Capobianco United States 15 300 1.6× 84 0.5× 125 0.8× 176 1.2× 181 1.7× 29 655
Timothy R. Kane Canada 5 287 1.5× 165 0.9× 255 1.7× 81 0.6× 83 0.8× 5 797
C.-J. Soussy France 15 146 0.8× 162 0.9× 272 1.8× 116 0.8× 223 2.1× 29 664
W. TOSCH Switzerland 10 274 1.5× 165 0.9× 237 1.5× 100 0.7× 117 1.1× 17 669

Countries citing papers authored by J. F. Desnottes

Since Specialization
Citations

This map shows the geographic impact of J. F. Desnottes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. F. Desnottes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. F. Desnottes more than expected).

Fields of papers citing papers by J. F. Desnottes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. F. Desnottes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. F. Desnottes. The network helps show where J. F. Desnottes may publish in the future.

Co-authorship network of co-authors of J. F. Desnottes

This figure shows the co-authorship network connecting the top 25 collaborators of J. F. Desnottes. A scholar is included among the top collaborators of J. F. Desnottes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. F. Desnottes. J. F. Desnottes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapuy‐Regaud, Sabine, Abiodun D. Ogunniyi, Yvette Huet, et al.. (2003). RegR, a Global LacI/GalR Family Regulator, Modulates Virulence and Competence in Streptococcus pneumoniae. Infection and Immunity. 71(5). 2615–2625. 38 indexed citations
2.
Desnottes, J. F., et al.. (2001). Synthesis and Activities of Pyoverdin−Quinolone Adducts: A Prospective Approach to a Specific Therapy Against Pseudomonas aeruginosa. Journal of Medicinal Chemistry. 44(13). 2139–2151. 67 indexed citations
3.
Beyer, D., et al.. (1998). ChemInform Abstract: Recent Developments in Streptogramin Research. ChemInform. 29(27).
4.
Desnottes, J. F., et al.. (1997). In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 39(suppl 1). 99–102. 12 indexed citations
5.
Huet, Yvette, et al.. (1997). Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis. Journal of Antimicrobial Chemotherapy. 39(suppl 1). 93–98. 8 indexed citations
6.
Desnottes, J. F.. (1996). New targets and strategies for the development of antibacterial agents. Trends in biotechnology. 14(4). 134–140. 27 indexed citations
7.
Desnottes, J. F.. (1996). Review of meeting: Antibiotic discovery: Exploiting new understanding of mechanism of action. Clinical Microbiology and Infection. 1(4). 281–285. 2 indexed citations
8.
Montay, Guy, et al.. (1995). Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia. Journal of Antimicrobial Chemotherapy. 36(2). 365–373. 13 indexed citations
9.
Desnottes, J. F., et al.. (1994). Effect of sparfloxacin on Staphylococcus aureus adhesiveness and phagocytosis. Journal of Antimicrobial Chemotherapy. 33(4). 737–746. 7 indexed citations
10.
Panteix, G., et al.. (1994). Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage. Journal of Antimicrobial Chemotherapy. 33(5). 979–985. 16 indexed citations
11.
Desnottes, J. F., et al.. (1993). Influence of sub-inhibitory concentrations of antibacterials on the surface properties and adhesion of Escherichia coil. Journal of Antimicrobial Chemotherapy. 31(1). 37–45. 15 indexed citations
12.
Desnottes, J. F., et al.. (1992). Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages. Journal of Antimicrobial Chemotherapy. 30(suppl A). 107–115. 30 indexed citations
13.
Andremont, Antoine, et al.. (1991). Effect of oral spiramycin on the faecal and oral bacteria in human volunteers. Journal of Antimicrobial Chemotherapy. 27(3). 355–360. 7 indexed citations
14.
Carlier, Marianne, Bernard Scorneaux, A. Zenebergh, J. F. Desnottes, & Paul M. Tulkens. (1990). Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. Journal of Antimicrobial Chemotherapy. 26(suppl B). 27–39. 97 indexed citations
15.
Desnottes, J. F., et al.. (1990). Effect of pefloxacin on microorganism: host cell interaction. Journal of Antimicrobial Chemotherapy. 26(suppl B). 17–26. 13 indexed citations
16.
Desnottes, J. F., et al.. (1989). [Effect of sub-inhibitory concentrations of cefixime on the morphology, hemagglutination and adhesiveness of urinary strains of Escherichia coli].. PubMed. 18(32). 1572–5. 4 indexed citations
17.
Desnottes, J. F., et al.. (1988). Effect of spiramycin on adhesiveness and phagocytosis of Gram-positive cocci. Journal of Antimicrobial Chemotherapy. 22(Supplement_B). 25–32. 4 indexed citations
18.
Kitzis, M, et al.. (1988). Spiramycin concentrations in lung tissue. Journal of Antimicrobial Chemotherapy. 22(Supplement_B). 123–126. 2 indexed citations
19.
Frydman, Armand, Y. Le Roux, J. F. Desnottes, et al.. (1988). Pharmacokinetics of spiramycin in man. Journal of Antimicrobial Chemotherapy. 22(Supplement_B). 93–103. 25 indexed citations
20.
Bensman, A, et al.. (1978). [Localization of urinary tract infection in children by immunofluorescent study of bacteriuria and measurement of humoral antibodies].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(3). 242–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026